| Hang Seng Index | 23.880 HKD | +0.100 | +0.421% | 690.61M | 16.54B | 23.794 (+0.361%) HKD as at 2025/03/26 | | |
| Hang Seng China Enterprises | 88.700 HKD | +0.180 | +0.203% | 124.27M | 11.06B | 88.133 (+0.644%) HKD as at 2025/03/25 | | |
| Hang Seng TECH Index | 5.460 HKD | +0.010 | +0.183% | 931.92M | 5.12B | 5.455 (+0.088%) HKD as at 2025/03/26 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 6.125 HKD | +0.035 | +0.575% | 370.16M | 2.30B | 6.122 (+0.046%) HKD as at 2025/03/26 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.808 HKD | -0.012 | -0.659% | 862.01M | 1.54B | 1.816 (-0.419%) HKD as at 2025/03/26 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.528 HKD | -0.024 | -0.940% | 200.58M | 503.84M | 2.560 (-1.235%) HKD as at 2025/03/26 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.220 HKD | +0.065 | +1.261% | 67.07M | 351.29M | 5.142 (+1.519%) HKD as at 2025/03/26 | | |
| Hang Seng TECH Index | 11.710 HKD | +0.040 | +0.343% | 26.60M | 312.06M | 11.566 (+1.242%) HKD as at 2025/03/25 | | |
| HSI ESG Enhanced Index (net total return index) | 48.800 HKD | +0.080 | +0.164% | 3.40M | 166.37M | 48.650 (+0.309%) HKD as at 2025/03/26 | | |
| Hang Seng TECH Index | 5.555 HKD | +0.035 | +0.634% | 28.38M | 157.55M | 5.478 (+1.409%) HKD as at 2025/03/25 | | |
| Hang Seng TECH Index | 7.070 HKD | +0.035 | +0.498% | 12.13M | 85.87M | 7.061 (+0.126%) HKD as at 2025/03/26 | | |
| FTSE China A50 | 13.780 HKD | +0.040 | +0.291% | 5.48M | 75.58M | 13.813 (-0.240%) HKD as at 2025/03/25 | | |
| CSI 300 | 43.300 HKD | 0.000 | 0.000% | 1.22M | 52.79M | 43.485 (-0.425%) HKD as at 2025/03/25 | | |
| CSI Hong Kong Dividend | 33.400 HKD | +0.100 | +0.300% | 1.27M | 42.22M | 33.410 (-0.028%) HKD as at 2025/03/26 | | |
| FTSE China A50 | 12.890 HKD | +0.050 | +0.389% | 2.36M | 30.47M | 12.833 (+0.448%) HKD as at 2025/03/26 | | |
| London Gold Fixing Price | 2,178.000 HKD | +4.000 | +0.184% | 11.76K | 25.54M | N/A | | |
| Hang Seng Hong Kong-Listed Biotech Index | 11.040 HKD | +0.590 | +5.646% | 2.10M | 22.41M | 10.544 (+4.708%) HKD as at 2025/03/26 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 5.620 HKD | +0.210 | +3.882% | 3.28M | 18.38M | 5.400 (+4.070%) HKD as at 2025/03/25 | | |
| Hang Seng China Enterprises | 10.950 HKD | +0.050 | +0.459% | 1.66M | 18.15M | 10.789 (+1.491%) HKD as at 2025/03/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.854 HKD | +0.033 | +4.019% | 12.56M | 10.69M | 0.820 (+4.121%) HKD as at 2025/03/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 14.760 HKD | +0.110 | +0.751% | 658.00K | 9.66M | 14.556 (+1.404%) HKD as at 2025/03/25 | | |
| Hang Seng Index | 22.360 CNY | +0.100 | +0.449% | 429.00K | 9.62M | 22.257 (+0.465%) CNY as at 2025/03/26 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.368 HKD | +0.020 | +0.597% | 2.69M | 9.12M | 3.339 (+0.866%) HKD as at 2025/03/26 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 3.748 HKD | -0.004 | -0.107% | 2.38M | 8.91M | 3.776 (-0.752%) HKD as at 2025/03/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.688 HKD | +0.006 | +0.163% | 2.19M | 8.06M | 3.732 (-1.171%) HKD as at 2025/03/25 | | |
| CSI 300 | 28.000 HKD | +0.060 | +0.215% | 282.50K | 7.91M | 28.037 (-0.132%) HKD as at 2025/03/25 | | |
| Hang Seng High Dividend Yield | 25.040 HKD | +0.100 | +0.401% | 266.22K | 6.67M | 24.908 (+0.529%) HKD as at 2025/03/25 | | |
| SSE Science and Technology Innovation Board 50 Index | 9.345 HKD | +0.085 | +0.918% | 641.00K | 5.99M | 9.363 (-0.187%) HKD as at 2025/03/25 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 10.770 HKD | -0.100 | -0.920% | 522.70K | 5.64M | 10.839 (-0.638%) HKD as at 2025/03/26 | | |
| MSCI China | 24.200 HKD | +0.120 | +0.498% | 231.56K | 5.61M | 23.972 (+0.951%) HKD as at 2025/03/25 | | |